Time to Relapse Following Rituximab Therapy in Rheumatoid Arthritis and Its Determinants: A Single-Center Observational Study.

El Moubarik I, El Binoune I, Rostom S, Ghoullam G, Amine B, Zemrani S, Zeghari Z, Bahiri R.

Open source

DOI
10.7759/cureus.110939
Published
2026-06-15
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.110939,
  title = {Time to Relapse Following Rituximab Therapy in Rheumatoid Arthritis and Its Determinants: A Single-Center Observational Study.},
  author = {El Moubarik I and  El Binoune I and  Rostom S and  Ghoullam G and  Amine B and  Zemrani S and  Zeghari Z and  Bahiri R.},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.110939},
  url = {https://doi.org/10.7759/cureus.110939}
}

RIS

TY  - JOUR
TI  - Time to Relapse Following Rituximab Therapy in Rheumatoid Arthritis and Its Determinants: A Single-Center Observational Study.
AU  - El Moubarik I
AU  -  El Binoune I
AU  -  Rostom S
AU  -  Ghoullam G
AU  -  Amine B
AU  -  Zemrani S
AU  -  Zeghari Z
AU  -  Bahiri R.
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.110939
UR  - https://doi.org/10.7759/cureus.110939
ER  - 

APA

I, E. M., I, E. B., S, R., G, G., B, A., S, Z., Z, Z., & R., B. (2026). Time to Relapse Following Rituximab Therapy in Rheumatoid Arthritis and Its Determinants: A Single-Center Observational Study.. Cureus. https://doi.org/10.7759/cureus.110939

Source records